Live Chat

CFD's zijn complexe instrumenten en gaan gepaard met een hoog risico snel kapitaal te verliezen als gevolg van hefboommechanismen. 74% an de retailbeleggers lijdt verlies op de handel in CFD's met deze aanbieder. U dient zorgvuldig te overwegen of u begrijpt hoe CFD's werken en of u het zich kunt veroorloven om hoge risico's te nemen op het verliezen van uw kapitaal.

Close

JnJ live grafieken

instrument_fundamentals

Weekly Search
Weekly
Daily
Datum Sluit Verandering % verandering Openen Piek Bodem

Info

Spread

0.95

Spread (%)

0.6262 %

Hefboom

1:2

Dagrente kopen

-0.0597 %

Dagrente verkopen

-0.0292 %

Valuta

USD

Openingstijden

Markt openen

Donderdag

14:31 - 20:59

Maandag

14:31-20:59

Dinsdag

14:31-20:59

Woensdag

14:31-20:59

Vrijdag

14:31-20:59

instr__analysis_statistics

Openen

---

Vorige Sluiten

---

52-weekse hoog/laag

--- – ---

Beurswaarde

368943726592

Uitstaande aandelen

2407620096

Datum winstcijfer (volgende)

2001-06-13

Div. rend.

2024-12-10

Ex-dividenddatum

2024-11-26

Jaarlijks verwachte dividendpercentage

4.96

Jaarlijks verwachte dividendrendement

0.0325

Winst per aandeel

6.07

Meer informatie over dit instrument

JnJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Gerelateerde instrumenten

Activa
Verkoop
Koop
% verandering
Gerelateerde instrumenten

Laatste marktnieuws

Blijf op de hoogte van het laatste financiële nieuws uit de hele wereld.

Dogecoin surges

Woensdag, 13 November 2024

Dogecoin surges as Trump unveils new government efficiency initiative with Musk andRamaswamy

Woensdag, 13 November 2024

Japanese Yen to USD: Yen drops to fresh multi-month low against USD

Woensdag, 13 November 2024

Asia markets today: Nikkei 225 up 0.18%, Hang Seng Index falls by 197 points

Dinsdag, 12 November 2024

UK stock market news: Helium One share price trading 16.1% higher

Dinsdag, 12 November 2024

Leveraged ETF to package Warren Buffett's Berkshire Hathaway B stock

Dinsdag, 12 November 2024

Dogecoin surges 20% after Department of Government Efficiency announcement

Dinsdag, 12 November 2024

Dow Jones Dips Ahead of CPI Inflation Data; Tesla shares up

Maandag, 11 November 2024

Stock market today: Trump trade powers Dow Johns, S&P 500, Tesla and bitcoin

Trustpilot
Live Chat